Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-02

Clinical Trial Update: Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the use of topical eflornithin after laser treatment for facial hirsutism in women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eflornithine hydrochloride cream (eflornithine hydrochloride)

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Hirsutism | Phase 4 | Status: COMPLETED